Dedifferentiated endometrioid adenocarcinoma with trophoblastic components: Prolonged remission after treatment with bleomycin, etoposide, and cisplatin
Dedifferentiated endometrial adenocarcinoma (DEAC) with trophoblastic components is a rare neoplasm with an aggressive behavior and a poor prognosis. Only seven cases have been reported in the literature. We present a 61-year-old patient who was diagnosed with Stage IB dedifferentiated endometrioid...
Saved in:
Main Authors: | Alexa K. Martin (Author), Elizabeth G. Jackson (Author), Henry D. Edwards (Author), Michael P. Stany (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dedifferentiated endometrioid adenocarcinoma of the uterus: A case series and review of literature
by: C. Goh, et al.
Published: (2020) -
Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis
by: Jen-Yin Hou, et al.
Published: (2015) -
Association between cumulative cisplatin dose and reproductive and sexual functions in patients with malignant ovarian germ cell tumors treated with bleomycin, etoposide, and cisplatin therapy: a case series study
by: Miki Akasaka, et al.
Published: (2022) -
Two Cases of Dedifferentiated Endometrioid Carcinoma: Case Presentation and Brief Review of the Literature
by: Sachiko Morioka, et al.
Published: (2018) -
Central-type primitive neuroectodermal tumor of the uterus: Case report of remission of stage IV disease using adjuvant cisplatin/etoposide/bevacizumab chemotherapy and review of the literature
by: Jorge Novo, et al.
Published: (2015)